Dual trigger with the combination of gonadotropin-releasing hormone agonist and standard dose of human chorionic gonadotropin improves in vitro fertilisation outcomes in poor ovarian responders

References

• Avrech OM, Goldman GA, Rufas O, Stein A, Amit S, Yoles I, et al. 1997. Treatment variables in relation to oocyte maturation: lessons from a clinical micromanipulation-assisted in vitro fertilization program. Journal of Assisted Reproduction and Genetics 14:337–342.
   PubMed Web of Science ®Google Scholar
• Beck-Fruchter R, Weiss A, Lavee M, Geslevich Y, Shalev E. 2012. Empty follicle syndrome: successful treatment in a recurrent case and review of the literature. Human Reproduction 27:1357–1367.
   PubMed Web of Science ®Google Scholar
• Bosch E, Labarta E, Kolibianakis E, Rosen M, Meldrum D. 2016. Regimen of ovarian stimulation affects oocyte and therefore embryo quality. Fertility and Sterility 105:560–570.
   PubMed Web of Science ®Google Scholar
• Casañ EM, Raga F, Bonilla-Musoles F, Polan ML. 2000. Human oviductal gonadotropin-releasing hormone: possible implications in fertilization, early embryonic development, and implantation. The Journal of Clinical Endocrinology and Metabolism 85:1377–1381.
   PubMed Web of Science ®Google Scholar
• Chern CU, Li JY, Tsui KH, Wang PH, Wen ZH, Lin LT. 2020. Dual-trigger improves the outcomes of in vitro fertilization cycles in older patients with diminished ovarian reserve: a retrospective cohort study. PLoS One 15:e0235707.
   PubMed Web of Science ®Google Scholar
• Cummins J, Breen T, Harrison K, Shaw J, Wilson L, Hennessey J. 1986. A formula for scoring human embryo growth rates in in vitro fertilization: its value in predicting pregnancy and in comparison with visual estimates of embryo quality. Journal of In Vitro Fertilization and Embryo Transfer 3:284–295.
   PubMedGoogle Scholar
• Engmann L, Diluigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. 2008. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertility and Sterility 89:84–91.
   PubMed Web of Science ®Google Scholar
• Ferraretti AP, Gianaroli L. 2014. The Bologna criteria for the definition of poor ovarian responders: is there a need for revision? Human Reproduction 29:1842–1845.
   PubMed Web of Science ®Google Scholar
• Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. 2000. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertility and Sterility 73:1155–1158.
   PubMed Web of Science ®Google Scholar
• Gonen Y, Balakier H, Powell W, Casper RF. 1990. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. The Journal of Clinical Endocrinology and Metabolism 71:918–922.
   PubMed Web of Science ®Google Scholar
• Griffin D, Benadiva C, Kummer N, Budinetz T, Nulsen J, Engmann L. 2012. Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders. Fertility and Sterility 97:1316–1320.
   PubMed Web of Science ®Google Scholar
• Griffin D, Feinn R, Engmann L, Nulsen J, Budinetz T, Benadiva C. 2014. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates. Fertility and Sterility 102:405–409.
   PubMed Web of Science ®Google Scholar
• Haas J, Bassil R, Samara N, Zilberberg E, Mehta C, Orvieto R, Casper RF. 2020. GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blinded, randomized controlled study. Human Reproduction 35:1648–1654.
   PubMed Web of Science ®Google Scholar
• Haas J, Ophir L, Barzilay E, Machtinger R, Yung Y, Orvieto R, Hourvitz A. 2016. Standard human chorionic gonadotropin versus double trigger for final oocyte maturation results in different granulosa cells gene expressions: a pilot study. Fertility and Sterility 106:653–659.e1.
   PubMed Web of Science ®Google Scholar
• Haas J, Zilberberg E, Dar S, Kedem A, Machtinger R, Orvieto R. 2014. Co-administration of GnRH-agonist and hCG for final oocyte maturation (double trigger) in patients with low number of oocytes retrieved per number of preovulatory follicles-a preliminary report. Journal of Ovarian Research 7:77.
   PubMed Web of Science ®Google Scholar
• Haas J, Zilberberg E, Nahum R, Mor Sason A, Hourvitz A, Gat I, Orvieto R. 2019. Does double trigger (GnRH-agonist + hCG) improve outcome in poor responders undergoing IVF-ET cycle? A pilot study. Gynecological Endocrinology 35:628–630.
   PubMed Web of Science ®Google Scholar
• Hernandez ER. 2000. Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists. Human Reproduction 15:1211–1216.
   PubMed Web of Science ®Google Scholar
• Humaidan P, Ejdrup Bredkjaer H, Bungum L, Bungum M, Grøndahl ML, Westergaard L, Yding Andersen C. 2005. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Human Reproduction 20:1213–1220.
   PubMed Web of Science ®Google Scholar
• Humaidan P, Kol S, Papanikolaou EG, Copenhagen GN. 2011. GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Human Reproduction Update 17:510–524.
   PubMed Web of Science ®Google Scholar
• Imoedemhe DA, Sigue AB, Pacpaco ELA, Olazo AB. 1991. Stimulation of endogenous surge of luteinizing hormone with gonadotropin-releasing hormone analog after ovarian stimulation for in vitro fertilization. Fertility and Sterility 55:328–332.
   PubMed Web of Science ®Google Scholar
• Jelodar G, Gholami S, Jafarpour F. 2007. Effect of GnRH on guinea pig endometrium at preimplantation stage. Indian Journal of Experimental Biology 45:242–246.
   PubMed Web of Science ®Google Scholar
• Kol S. 2004. Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertility and Sterility 81:1–5.
   PubMed Web of Science ®Google Scholar
• Kol S, Lewit N, Itskovitz-Eldor J. 1996. Ovarian hyperstimulation: effects of GnRH analogues. Ovarian hyperstimulation syndrome after using gonadotrophin-releasing hormone analogue as a trigger of ovulation: causes and implications. Human Reproduction 11:1143–1144.
   PubMed Web of Science ®Google Scholar
• Kolibianakis EM, Schultze-Mosgau A, Schroer A, Van Steirteghem A, Devroey P, Diedrich K, Griesinger G. 2005. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Human Reproduction 20:2887–2892.
   PubMed Web of Science ®Google Scholar
• Lin M-H, Wu FS-Y, Hwu Y-M, Lee RK-K, Li R-S, Li S-H. 2019. Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve. Reproductive Biology and Endocrinology 17:7.
   PubMed Web of Science ®Google Scholar
• Lin M-H, Wu FS-Y, Lee RK-K, Li S-H, Lin S-Y, Hwu Y-M. 2013. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles. Fertility and Sterility 100:1296–1302.
   PubMed Web of Science ®Google Scholar
• Liu J, Cao B, Li Y-X, Wu X-Q, Wang Y-L. 2010. GnRH I and II up-regulate MMP-26 expression through the JNK pathway in human cytotrophoblasts. Reproductive Biology and Endocrinology 8:5.
   PubMed Web of Science ®Google Scholar
• Liu J, Maccalman CD, Wang Y-L, Leung PC. 2009. Promotion of human trophoblasts invasion by gonadotropin-releasing hormone (GnRH) I and GnRH II via distinct signaling pathways. Molecular Endocrinology 23:1014–1021.
   PubMedGoogle Scholar
• Maged AM, Ragab MA, Shohayeb A, Saber W, Ekladious S, Hussein EA, et al. 2020. Comparative study between single versus dual trigger for poor responders in GnRH-antagonist ICSI cycles: a randomized controlled study. International Journal of Gynecology & Obstetrics 152:395–400.
   PubMed Web of Science ®Google Scholar
• Oliveira JBA, Baruffi R, Petersen CG, Mauri AL, Cavagna M, Franco JG. 2010. Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis. Reproductive Biology and Endocrinology 8:107.
   PubMed Web of Science ®Google Scholar
• Orvieto R. 2005. Can we eliminate severe ovarian hyperstimulation syndrome? Human Reproduction (Oxford, England) 20:320–322.
   PubMed Web of Science ®Google Scholar
• Park J-Y, Su Y-Q, Ariga M, Law E, Jin S-LC, Conti M. 2004. EGF-like growth factors as mediators of LH action in the ovulatory follicle. Science 303:682–684.
   PubMed Web of Science ®Google Scholar
• Raga F, Casan EM, Kruessel JS, Wen Y, Huang H-Y, Nezhat C, Polan ML. 1998. Quantitative gonadotropin-releasing hormone gene expression and immunohistochemical localization in human endometrium throughout the menstrual cycle. Biology of Reproduction 59:661–669.
   PubMed Web of Science ®Google Scholar
• Richards JS, Ireland JJ, Rao MC, Bernath GA, Midgley AR, Reichert LE. 1976. Ovarian follicular development in the rat: hormone receptor regulation by estradiol, follicle stimulating hormone and luteinizing hormone. Endocrinology 99:1562–1570.
   PubMed Web of Science ®Google Scholar
• Rosen MP, Zamah AM, Shen S, Dobson AT, Mcculloch CE, Rinaudo PF, et al. 2009. The effect of follicular fluid hormones on oocyte recovery after ovarian stimulation: FSH level predicts oocyte recovery. Reproductive Biology and Endocrinology 7:35.
   PubMed Web of Science ®Google Scholar
• Sasaki K, Norwitz ER. 2011. Gonadotropin-releasing hormone/gonadotropin-releasing hormone receptor signaling in the placenta. Current Opinion in Endocrinology, Diabetes and Obesity 18:401–408.
   PubMedGoogle Scholar
• Schachter M, Friedler S, Ron-El R, Zimmerman AL, Strassburger D, Bern O, Raziel A. 2008. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study. Fertility and Sterility 90:1087–1093.
   PubMed Web of Science ®Google Scholar
• Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Thomas S. 2008. Gonadotropin-re leasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization. Fertility and Sterility 90:231–233.
   PubMed Web of Science ®Google Scholar
• Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C. 2011. Comparison of “triggers” using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin. Fertility and Sterility 95:2715–2717.
   PubMed Web of Science ®Google Scholar
• Yu B, Ruman J, Christman G. 2011. The role of peripheral gonadotropin-releasing hormone receptors in female reproduction. Fertility and Sterility 95:465–473.
   PubMed Web of Science ®Google Scholar
• Zeleznik AJ, Midgley AR, Reichert LE. 1974. Granulosa cell maturation in the rat: increased binding of human chorionic gonadotropin following treatment with follicle-stimulating hormone in vivo. Endocrinology 95:818–825.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang Y, Mao X, Chen Q, Hong Q, Cai R, et al. 2017. Dual trigger of final oocyte maturation in poor ovarian responders undergoing IVF/ICSI cycles. Reproductive BioMedicine Online 35:701–707.
   PubMed Web of Science ®Google Scholar
• Zilberberg E, Haas J, Dar S, Kedem A, Machtinger R, Orvieto R. 2015. Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes. Gynecological Endocrinology 31:145–147.
   PubMed Web of Science ®Google Scholar